Literature DB >> 12466119

The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

Guido A Hegasy1, Tamara Manuelian, Kolbjorn Hogasen, Johan H Jansen, Peter F Zipfel.   

Abstract

Porcine membranoproliferative glomerulonephritis type II in piglets of the Norwegian Yorkshire breed is considered the first animal model of human dense deposit disease. Porcine dense deposit disease is caused by the absence of the complement regulator factor H in plasma. Here we report the molecular basis for this absence. Single nucleotide exchanges at position C1590G and T3610G in the coding region of the factor H gene result in amino acid exchanges at nonframework residues L493V and I1166R that are located within SCR 9 and SCR 20, respectively. Apparently the L493V mutation represents a polymorphism whereas the I1166R causes the physiological consequences a block in protein secretion. Expression analysis shows comparable mRNA levels for factor H in liver tissue derived from both affected and healthy animals. In affected piglets, factor H protein is detected in increased amounts in liver cells. Factor H accumulates inside the hepatocytes and is not released as shown by Western blot analysis and immunohistochemistry. These data demonstrate that single amino acid exchanges of two nonframework amino acids either alone or in combination block protein secretion of factor H. This observation is also of interest for other human diseases in which factor H is involved, such as human factor H-associated form of hemolytic uremic syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466119      PMCID: PMC1850924          DOI: 10.1016/S0002-9440(10)64481-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Complement factor H and the haemolytic uraemic syndrome.

Authors:  C M Taylor
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

Review 2.  Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?

Authors:  P F Zipfel
Journal:  Trends Immunol       Date:  2001-07       Impact factor: 16.687

3.  Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Daniela Codazzi; Marina Noris; Jessica Caprioli; Giuseppe Locatelli; Bruno Gridelli
Journal:  Lancet       Date:  2002-05-11       Impact factor: 79.321

Review 4.  Hemolytic-uremic syndrome and complement factor H deficiency: clinical aspects.

Authors:  C M Taylor
Journal:  Semin Thromb Hemost       Date:  2001-06       Impact factor: 4.180

5.  The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Authors:  Jessica Caprioli; Paola Bettinaglio; Peter F Zipfel; Barbara Amadei; Erica Daina; Sara Gamba; Christine Skerka; Nicola Marziliano; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

6.  Disruption of disulfide bonds is responsible for impaired secretion in human complement factor H deficiency.

Authors:  B Z Schmidt; N L Fowler; T Hidvegi; D H Perlmutter; H R Colten
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 7.  Factor H and the pathogenesis of renal diseases.

Authors:  B H Ault
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

8.  Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.

Authors:  D Pérez-Caballero; C González-Rubio; M E Gallardo; M Vera; M López-Trascasa; S Rodríguez de Córdoba; P Sánchez-Corral
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

9.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.

Authors:  A Richards; M R Buddles; R L Donne; B S Kaplan; E Kirk; M C Venning; C L Tielemans; J A Goodship; T H Goodship
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

10.  Rat complement factor H: molecular cloning, sequencing and quantification with a newly established ELISA.

Authors:  T Demberg; B Pollok-Kopp; D Gerke; O Götze; G Schlaf
Journal:  Scand J Immunol       Date:  2002-08       Impact factor: 3.487

View more
  18 in total

Review 1.  Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

Authors:  Julien Zuber; Fadi Fakhouri; Lubka T Roumenina; Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Nat Rev Nephrol       Date:  2012-10-02       Impact factor: 28.314

2.  MPGN II--genetically determined by defective complement regulation?

Authors:  Christoph Licht; Ursula Schlötzer-Schrehardt; Michael Kirschfink; Peter F Zipfel; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2006-09-23       Impact factor: 3.714

Review 3.  Dense deposit disease.

Authors:  Richard J H Smith; Claire L Harris; Matthew C Pickering
Journal:  Mol Immunol       Date:  2011-05-24       Impact factor: 4.407

Review 4.  Making sense of the spectrum of glomerular disease associated with complement dysregulation.

Authors:  Sally Ann Johnson; Edwin K S Wong; C Mark Taylor
Journal:  Pediatr Nephrol       Date:  2013-07-14       Impact factor: 3.714

5.  A case of C3 glomerulonephritis successfully treated with eculizumab.

Authors:  Alexis Payette; Natalie Patey; Marie-Agnès Dragon-Durey; Véronique Frémeaux-Bacchi; Françoise Le Deist; Anne-Laure Lapeyraque
Journal:  Pediatr Nephrol       Date:  2015-03-22       Impact factor: 3.714

6.  Pig complement regulator factor H: molecular cloning and functional characterization.

Authors:  Guido A Hegasy; Ute Willhoeft; Sandra A Majno; Harald Seeberger; Peter F Zipfel; Jens Hellwage
Journal:  Immunogenetics       Date:  2003-09-27       Impact factor: 2.846

Review 7.  Genetics and complement in atypical HUS.

Authors:  David Kavanagh; Tim Goodship
Journal:  Pediatr Nephrol       Date:  2010-06-06       Impact factor: 3.714

8.  Is renal function associated with early age-related macular degeneration?

Authors:  Elaine W Chong; Robyn H Guymer; Ronald Klein; Barbara E Klein; Mary Frances Cotch; Jie Jin Wang; Michael G Shlipak; Tien Y Wong
Journal:  Optom Vis Sci       Date:  2014-08       Impact factor: 1.973

Review 9.  Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.

Authors:  M C Pickering; H T Cook
Journal:  Clin Exp Immunol       Date:  2008-02       Impact factor: 4.330

10.  Dense deposit disease and the factor H H402 allele.

Authors:  Keith K Lau; Richard J Smith; Peter C Kolbeck; Lavjay Butani
Journal:  Clin Exp Nephrol       Date:  2008-01-26       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.